[Risk stratification of sudden death in hypertrophic cardiomyopathy in 2016].

[Risk stratification of sudden death in hypertrophic cardiomyopathy in 2016].
Presse Med. 2016 May 24;
Authors: Dubourg O, Charron P, Sirol M, Siam-Tsieu V, Mansencal N
Abstract
Patients with hypertrophic cardiomyopathy (HCM) are at an increased risk of death from many causes and sudden cardiac death is one of them. The study of the sudden cardiac death of patients with HCM has allowed the identification of risk factors and among them major risk factor are: family history of sudden cardiac death, the occurrence of syncope/dizziness, the existence of non-sustained ventricular tachycardia an abnormal blood pressure response during stress test, presence of severe left ventricular hypertrophy≥30mm. Risk stratification for sudden cardiac death is essential, for symptomatic or asymptomatic HCM patients. Two approaches are possible: the classical approach or risk stratification methods with major risk factors and the new approach using the risk-calculator recommended by the ESC. Both methods are not in opposition but complementary. The risk stratification in hypertrophic cardiomyopathy should be still improved to be sure that only the most high-risk patients receive an implantable cardiac defibrillator.
PMID: 27234906 [PubMed - as supplied by publisher]

Source: Presse Medicale - May 23, 2016 Category: Journals (General) Authors: Dubourg O, Charron P, Sirol M, Siam-Tsieu V, Mansencal N Tags: Presse Med Source Type: research